Synpromics announces partnership with Lonza Pharma & Biotech

Lonza chooses Synpromics’ novel inducible promoter platform to  manufacture  biopharmaceuticals Edinburgh, UK, 16th May 2019 / Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible promoters to improve the manufacturing of biopharmaceuticals. The … Continued

Arecor: New Global Partner Signed & Clinical Trial Update

Cambridge, UK., 3rd May 2019: Arecor, today announces that it has signed a collaboration with a new major global pharmaceutical partner. Under the collaboration, Arecor will leverage its ArestatTM technology to develop superior liquid formulations of its partner’s proprietary products. The partner will … Continued

Mologic expands US and UK operations

Calculus Capital portfolio company, Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the latest phase of the Company’s expansion plans. Significant to this has been the opening of … Continued

Arecor appoints Chief Financial Officer

Calculus Capital portfolio company, Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, is pleased to announce the appointment of Susan Lowther as Chief … Continued